SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Brennan Nora (Last) (First) (Middle) 11500 S. EASTERN AVE. SUITE 240 (Street) HENDERSON NV 89052 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 12/10/2020	3. Issuer Name and Ticker or Trading Symbol SPECTRUM PHARMACEUTICALS INC [ SPPI ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Kurt A. Gustafson, attorney-in-fact for Nora E. Brennan	12/14/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY

AUTHORIZATION

I hereby authorize Joseph W. Turgeon, Kurt A. Gustafson and Keith M. McGahan,
acting singly, to sign and file on my behalf any and all forms required by the
Securities and Exchange Commission pursuant to Section 16 of the Securities
Exchange Act of 1934 (the "Exchange Act") relating to the reporting of
beneficial ownership of equity securities of Spectrum Pharmaceuticals, Inc.,
a Delaware corporation (the "Company"), and of changes in such beneficial
ownership, together with any and all amendments thereto.  This authorization
shall be effective on and after the date set forth below and shall continue
in effect until I am no longer required to file such forms, unless
earlier revoked by me in writing.

I acknowledge that the persons authorized hereunder are not assuming,
nor is the Company assuming, any of my responsibilities to comply with
Section 16 of the Exchange Act.

Dated as of this 11th day of December 2020.

/s/ Nora E. Brennan
Nora E. Brennan